Novartis investigative site

Bari 70124

0 studies enrolling now · 6 studies all time

What they study most

Acute Lymphoblastic Leukemia, Alzheimer Disease, Cardiovascular Disease and Lipoprotein(a), Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Multiple Sclerosis, RRMS

Studies at this site

• A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis — Completed
• Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia — Completed
• Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE